{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:07:26Z","timestamp":1768892846097,"version":"3.49.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00277-018-3279-8","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T14:40:46Z","timestamp":1518878446000},"page":"1489-1491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma"],"prefix":"10.1007","volume":"97","author":[{"given":"Tomonori","family":"Nakazato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoharu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisako","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Osada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Aisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"3279_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3109\/10428194.2011.625101","volume":"53","author":"M Tokuhira","year":"2012","unstructured":"Tokuhira M, Watanabe R, Nemoto T, Sagawa M, Tomikawa T, Tamaru JI, Itoyama S, Nagasawa H, Amano K, Kameda H, Takeuchi T, Mori S, Kizaki M (2012) Clinicopathological analysis in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma 53:616\u2013623","journal-title":"Leuk Lymphoma"},{"key":"3279_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ejh.12116","volume":"91","author":"A Ichikawa","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, Kimura Y, Takeuchi M, Yoshida M, Ishibashi Y, Nakashima S, Sugita Y, Miura O, Ohshima K (2013) Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91:20\u201328","journal-title":"Eur J Haematol"},{"key":"3279_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/cas.13249","volume":"108","author":"Y Gion","year":"2017","unstructured":"Gion Y, Iwaki N, Tanaka K et al (2017) Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci 108:1271\u20131280","journal-title":"Cancer Sci"},{"key":"3279_CR4","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/rheumatology\/keu374","volume":"53","author":"P Vachhani","year":"2014","unstructured":"Vachhani P, Bose N, Brodeur JP, Holkova B, Bose P (2014) Remission of rheumatoid arthritis on brentuximab vedotin. Rheumatology 53:2314\u20132315","journal-title":"Rheumatology"},{"key":"3279_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1365-2249.1995.tb03851.x","volume":"102","author":"R Gerli","year":"1995","unstructured":"Gerli R, Muscat C, Bistoni O, Falini B, Tomassini C, Agea E, Tognellini R, Biagini P, Bertotto A (1995) High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints. Clin Exp Immunol 102:547\u2013550","journal-title":"Clin Exp Immunol"},{"key":"3279_CR6","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.4049\/jimmunol.164.8.4399","volume":"164","author":"R Gerli","year":"2000","unstructured":"Gerli R, Pitzalis C, Bistoni O, Falini B, Costantini V, Russano A, Lunardi C (2000) CD30+ T cells in rheumatoid arthritis: mechanisms of recruitment and functional role. J Immunol 164:4399\u20134407","journal-title":"J Immunol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3279-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3279-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3279-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T03:30:14Z","timestamp":1550374214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3279-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3279"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3279-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from the patient for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}